Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
2267 On Other Exchanges
2267 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

yakult honsha co ltd (2267) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for YAKULT HONSHA CO LTD (2267)

Related News

No related news articles were found.

yakult honsha co ltd (2267) Related Businessweek News

View More BusinessWeek News

yakult honsha co ltd (2267) Details

Yakult Honsha Co., Ltd. manufactures and sells food and beverage products. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, a cancer chemotherapeutic agent for the treatment of colorectal cancer; Levofolinate Yakult, an activated folic acid drug; Gemcitabine Yakult, an antineoplastic antimetabolite; Imatinib yakult, a generic antineoplastic drug; Zoledronic acid Yakult, a generic drug for bone lesions; and Campto, a cancer chemotherapeutic agent. In addition, the company is developing Elplat for gastric cancer. Further, it offers cosmetics and skin care products under the Parabio, Revecy, and Revecy White brand names; Bellefin moisture essence, a moisturizing serum; Yakult sunscreen S.E. series; Crystance white repair essence, a whitening serum; and Yakult treatment repair mask, a face mask, as well as operates and manages the Tokyo Yakult Swallows, a professional baseball team. The company was founded in 1935 and is headquartered in Tokyo, Japan.

20,492 Employees
Last Reported Date: 06/25/15
Founded in 1935

yakult honsha co ltd (2267) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: ¥150.0M
Compensation as of Fiscal Year 2015.

yakult honsha co ltd (2267) Key Developments

Yakult Honsha Co, Ltd. Obtains Approval for Supplemental New Drug Application Elplat® Approbation in Gastric Cancer in Japan

Debiopharm International SA announced that its partner Yakult Honsha Co Ltd. obtained approval for a supplemental new drug application for Elplat® in postoperative adjuvant chemotherapy in gastric cancer, expanding the indications for this product (50 mg, 100 mg and 200 mg). This supplemental new drug application was approved mainly based on the results of two clinical studies; a phase III study which was conducted outside Japan to verify the benefits of the combination therapy with Elplat® and an anticancer drug, capecitabine (CLASSIC study), and a phase II study which was jointly conducted by Yakult Honsha Co. Ltd. and Chugai Pharmaceutical Co. Ltd. in Japan. Oxaliplatin is the active ingredient of Elplat®, a diaminocyclohexane (DACH) platin. Developed by Debiopharm, it has dramatically changed the prognosis of colorectal as well as pancreatic cancers. Debiopharm is the licensor of Elplat® to Yakult for the development and commercialization in Japan.

Yakult Honsha Co. Ltd. to Report Q2, 2016 Results on Nov 13, 2015

Yakult Honsha Co. Ltd. announced that they will report Q2, 2016 results on Nov 13, 2015

Yakult Honsha Co. Ltd. Announces Consolidated and Non-Consolidated Earnings Results for the Six Months Ended September 30, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2016

Yakult Honsha Co. Ltd. announced consolidated and non-consolidated earnings results for the six months ended September 30, 2015. For the period, on consolidated basis, the company reported net sales of ¥194,291 million against ¥180,498 million a year ago. Operating income was ¥22,424 million against ¥16,644 million a year ago. Income before income taxes and minority interests was ¥28,259 million against ¥20,615 million a year ago. Net income was ¥16,989 million against ¥12,014 million a year ago. Cash flows from operating activities ¥28,831 million against ¥23,331 million a year ago. For the period, non-consolidated basis, the company reported net sales of ¥91,413 million against ¥89,164 million a year ago. Operating income was ¥3,200 million against ¥1,386 million a year ago. Net income was ¥6,972 million against ¥4,523 million a year ago. Income before income taxes was ¥8,397 million against ¥5,447 million a year ago. The company provided consolidated earnings guidance for the fiscal year ending March 31, 2016. On consolidated basis, the company expects net sales of ¥395,000 million. The company expects operating income of ¥41,000 million and net income of ¥30,000 million.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2267:JP ¥6,080.00 JPY -30.00

2267 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 5,218 INR +12.60
BioGaia AB kr289.00 SEK +4.50
Biostime International Holdings Ltd $13.06 HKD -0.02
Mead Johnson Nutrition Co $80.99 USD -1.02
View Industry Companies

Industry Analysis


Industry Average

Valuation 2267 Industry Range
Price/Earnings 32.8x
Price/Sales 2.6x
Price/Book 2.9x
Price/Cash Flow 32.8x
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact YAKULT HONSHA CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at